Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jeroen D. F. Kerrebijn is active.

Publication


Featured researches published by Jeroen D. F. Kerrebijn.


Molecular Imaging and Biology | 2011

Optical Image-guided Surgery—Where Do We Stand?

Stijn Keereweer; Jeroen D. F. Kerrebijn; Pieter B. A. A. Van Driel; Bangwen Xie; Eric L. Kaijzel; Thomas J. A. Snoeks; Ivo Que; Merlijn Hutteman; Joost R. van der Vorst; J. Sven D. Mieog; Alexander L. Vahrmeijer; Cornelis J. H. van de Velde; Robert J. Baatenburg de Jong; Clemens W.G.M. Löwik

In cancer surgery, intra-operative assessment of the tumor-free margin, which is critical for the prognosis of the patient, relies on the visual appearance and palpation of the tumor. Optical imaging techniques provide real-time visualization of the tumor, warranting intra-operative image-guided surgery. Within this field, imaging in the near-infrared light spectrum offers two essential advantages: increased tissue penetration of light and an increased signal-to-background-ratio of contrast agents. In this article, we review the various techniques, contrast agents, and camera systems that are currently used for image-guided surgery. Furthermore, we provide an overview of the wide range of molecular contrast agents targeting specific hallmarks of cancer and we describe perspectives on its future use in cancer surgery.


Clinical Cancer Research | 2013

Optical Image-Guided Cancer Surgery: Challenges and Limitations

Stijn Keereweer; Pieter B. A. A. Van Driel; Thomas J. A. Snoeks; Jeroen D. F. Kerrebijn; Robert J. Baatenburg de Jong; Alexander L. Vahrmeijer; Henricus J. C. M. Sterenborg; Clemens W.G.M. Löwik

Optical image-guided cancer surgery is a promising technique to adequately determine tumor margins by tumor-specific targeting, potentially resulting in complete resection of tumor tissue with improved survival. However, identification of the photons coming from the fluorescent contrast agent is complicated by autofluorescence, optical tissue properties, and accurate fluorescent targeting agents and imaging systems. All these factors have an important influence on the image that is presented to the surgeon. Considering the clinical consequences at stake, it is a prerequisite to answer the questions that are essential for the surgeon. What is optical image-guided surgery and how can it improve patient care? What should the oncologic surgeon know about the fundamental principles of optical imaging to understand which conclusions can be drawn from the images? And how do the limitations influence clinical decision making? This article discusses these questions and provides a clear overview of the basic principles and practical applications. Although there are limitations to the intrinsic capacity of the technique, when practical and technical surgical possibilities are considered, optical imaging can be a very powerful intraoperative tool in guiding the future oncologic surgeon toward radical resection and optimal clinical results. Clin Cancer Res; 19(14); 3745–54. ©2013 AACR.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2012

IMAGE-GUIDED SURGERY IN HEAD AND NECK CANCER: CURRENT PRACTICE AND FUTURE DIRECTIONS OF OPTICAL IMAGING

Stijn Keereweer; H. J. C. M. Sterenborg; Jeroen D. F. Kerrebijn; P. B. A. A. van Driel; R. J. Baatenburg de Jong; Clemens W.G.M. Löwik

A key aspect for the postoperative prognosis of patients with head and neck cancer is complete tumor resection. In current practice, the intraoperative assessment of the tumor‐free margin is dependent on visual appearance and palpation of the tumor. Optical imaging has the potential of traversing the gap between radiology and surgery by providing real‐time visualization of the tumor, thereby allowing for image‐guided surgery. The use of the near‐infrared light spectrum offers 2 essential advantages: increased tissue penetration of light and an increased signal‐to‐background ratio of contrast agents.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2001

CO2-laser treatment of recurrent glottic carcinoma

Henriëtte H. W. de Gier; Paul Knegt; Maarten F. de Boer; Cees A. Meeuwis; Lilly-Ann van der Velden; Jeroen D. F. Kerrebijn

Evaluation of the results of CO2 laser treatment of recurrent glottic carcinoma after radiotherapy.


Journal of Surgical Oncology | 2012

Targeting integrins and enhanced permeability and retention (EPR) effect for optical imaging of oral cancer.

Stijn Keereweer; Isabel M. Mol; Jeroen D. F. Kerrebijn; Pieter B. A. A. Van Driel; Bangwen Xie; Robert J. Baatenburg de Jong; Alexander L. Vahrmeijer; Clemens W.G.M. Löwik

Near‐infrared (NIR) fluorescence optical imaging is a promising technique to assess the tumor margins during cancer surgery. This technique requires targeting by specific fluorescence agents to differentiate tumor from normal surrounding tissue. We assessed the feasibility of cancer detection using NIR fluorescence agents that target either αvβ3 integrins or the enhanced permeability and retention (EPR) effect in an orthotopic mouse model of oral cancer.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2005

Partial laryngectomy for recurrent glottic carcinoma after radiotherapy

Aniel Sewnaik; C.A. Meeuwis; Theo H. van der Kwast; Jeroen D. F. Kerrebijn

Early laryngeal cancer is treated with surgery or radiotherapy. A partial laryngectomy instead of a total laryngectomy can be used for treating patients with radiation failures.


Clinical Otolaryngology | 2005

Treatment of hypopharyngeal carcinoma: analysis of nationwide study in the Netherlands over a 10-year period.

A. Sewnaik; J.J. Hoorweg; P.P. Knegt; M.H. Wieringa; J.M.H. Beek; Jeroen D. F. Kerrebijn

Objective:  To analyse different treatment strategies and treatment results of hypopharyngeal carcinoma in the Netherlands.


Otolaryngology-Head and Neck Surgery | 2005

Surgery for recurrent laryngeal carcinoma after radiotherapy: Partial laryngectomy or total laryngectomy for a better quality of life?

Aniel Sewnaik; Jaap L. Van Den Brink; Marjan H. Wieringa; C.A. Meeuwis; Jeroen D. F. Kerrebijn

OBJECTIVE To investigate the quality of life after partial laryngectomy versus total laryngectomy for recurrent laryngeal carcinomas after radiotherapy. STUDY DESIGN AND SETTING: A retrospective study performed at least one year after treatment. This study was performed in a university hospital. RESULTS: Twenty-three patients (N = 12 partial laryngectomy, N = 11 total laryngectomy) with recurrent laryngeal cancer after radiotherapy were included in the study. Three different questionnaires, 1) EORTC Quality of Life Questionnaire (QLQ)-C30 Dutch version 3.0, 2) EORTC-H & N 35, and 3) the Voice Handicap Index, were sent to all patients. The only major difference in quality of life of patients after partial laryngectomy versus total laryngectomy was found to be smell and taste related. No other differences were found. CONCLUSION: We did not find much difference in quality of life after treatment with a partial laryngectomy or a total laryngectomy in patients with recurrent laryngeal cancer after radiotherapy.


Laryngoscope | 2013

The impact of treatment modality and radiation technique on outcomes and toxicity of patients with locally advanced oropharyngeal cancer

Abrahim Al-Mamgani; Peter van Rooij; Gerda M. Verduijn; Robert Mehilal; Jeroen D. F. Kerrebijn; Peter C. Levendag

To investigate the impact of treatment modality and radiation technique on oncologic outcomes and toxicity of patients with locally advanced oropharyngeal cancer (OPC).


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2012

Optical imaging of oral squamous cell carcinoma and cervical lymph node metastasis

Stijn Keereweer; Jeroen D. F. Kerrebijn; Isabel M. Mol; J. Sven D. Mieog; Pieter B. A. A. Van Driel; Robert J. Baatenburg de Jong; Alexander L. Vahrmeijer; Clemens W.G.M. Löwik

In oral cancer surgery, intraoperative optical imaging could help the surgeon to determine adequate tumor‐free margins.

Collaboration


Dive into the Jeroen D. F. Kerrebijn's collaboration.

Top Co-Authors

Avatar

Stijn Keereweer

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Clemens W.G.M. Löwik

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Alexander L. Vahrmeijer

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Pieter B. A. A. Van Driel

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Paul Knegt

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

C.A. Meeuwis

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Cees A. Meeuwis

Erasmus University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Aniel Sewnaik

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Hemmo A. Drexhage

Erasmus University Rotterdam

View shared research outputs
Researchain Logo
Decentralizing Knowledge